HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Valerio Chiroli Selected Research

1-(nitrooxymethyl)-2-(nitrooxy)ethyl 7- (3,5- dihydroxy- 2- (3- hydroxy- 5- phenylpentyl)cyclopentyl)- 5- heptenoate

4/2010A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Valerio Chiroli Research Topics

Disease

2Ocular Hypertension (Glaucoma, Suspect)
09/2011 - 04/2010
2Glaucoma
09/2011 - 04/2010
1Eye Diseases (Eye Disease)
04/2011

Drug/Important Bio-Agent (IBA)

1BOL 303259-XIBA
09/2011
1GlucocorticoidsIBA
04/2011
1Synthetic Prostaglandins (Prostaglandin Analogues)IBA
04/2010
1Latanoprost (Xalatan)FDA Link
04/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2010
11-(nitrooxymethyl)-2-(nitrooxy)ethyl 7- (3,5- dihydroxy- 2- (3- hydroxy- 5- phenylpentyl)cyclopentyl)- 5- heptenoateIBA
04/2010

Therapy/Procedure

2Lasers (Laser)
09/2011 - 04/2010